Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Ovarian cancer
Closed
Phase 1/2
This trial is looking at a new drug called GSK2110183 alongside carboplatin and paclitaxel for ovarian cancer that has come back after platinum chemotherapy. It is for women who have ovarian cancer, fallopian tube cancer or primary peritoneal cancer. When we use the term ovarian cancer in this summary, we are referring to all 3.
Recruitment start: 1 December 2012
Recruitment end: 1 October 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Sarah Blagden
Accenture
Experimental Cancer Medicine Centre (ECMC)
GlaxoSmithKline (GSK)
NIHR Clinical Research Network: Cancer
Last reviewed: 5 December 2014
CRUK internal database number: 10687
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
